Fibrinolytic activity in rheumatoid arthritis and the effects of prednisolone therapy

Fibrinolytic activity in rheumatoid arthritis and the effects of prednisolone therapy

The relationship between disease activity and fibrinolytic activity was investigated in 40 patients with rheumatoid arthritis (RA). There was no difference in global fibrinolytic activity between RA and controls, 220 (200-330) and 280 (167-346) min respectively although inhibition of plasminogen act...

Bibliografski detalji
Glavni autori:	Gough, S, Pullar, T, Rice, P, Zebouni, L, Grant, P
Format:	Journal article
Jezik:	English
Izdano:	1993

Slični predmeti

The effect of exercise and heart rate on fibrinolytic activity.
od: Gough, S, i dr.
Izdano: (1992)

The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterisation.
od: Gough, S, i dr.
Izdano: (1992)

The fibrinolytic system in diabetes mellitus.
od: Gough, S, i dr.
Izdano: (1991)

Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
od: Edwards, C, i dr.
Izdano: (2008)

The fibrinolytic response to exercise at diagnosis and after 12 months in patients with type 2 diabetes mellitus
od: Gough, S, i dr.
Izdano: (1994)

Co-Delivery of Prednisolone and Curcumin in Human Serum Albumin Nanoparticles for Effective Treatment of Rheumatoid Arthritis
od: Yan F, i dr.
Izdano: (2019-11-01)

Insulin resistance and alterations in the fibrinolytic system
od: Gough, S, i dr.
Izdano: (1993)

Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study
od: Uta Kiltz, i dr.
Izdano: (2017-04-01)

Fibrinolytic Therapy in Purulent Pericarditis
od: Małgorzata Dybowska, i dr.
Izdano: (2023-01-01)

Effect of long-term low dose prednisolone administration on bone mineral density: Relating to non-compliant women with rheumatoid arthritis
od: Behzad Heidari, i dr.
Izdano: (2018-01-01)

AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study
od: Jacob M. vanLaar, i dr.
Izdano: (2023-12-01)

Antibody therapy for rheumatoid arthritis.
od: Taylor, P
Izdano: (2003)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
od: Hidesaku Asakura, i dr.
Izdano: (2020-09-01)

BIOBEHAVIORAL THERAPY OF RHEUMATOID ARTHRITIS
od: N. A. Shabanova, i dr.
Izdano: (2013-04-01)

Anti-cytokine therapy for rheumatoid arthritis.
od: Maini, R, i dr.
Izdano: (2000)

The effect of exercise and heart rate on fibrinolytic activity.
od: Dewar, H, i dr.
Izdano: (1993)

Infliximab in the therapy of rheumatoid arthritis
od: G. V. Lukina, i dr.
Izdano: (2016-05-01)

A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients
od: Naureen Narula, i dr.
Izdano: (2021-01-01)

Fournier's gangrene that initially mimicked pubic cellulitis in an elderly woman administered a Janus kinase inhibitor, methotrexate, and prednisolone for rheumatoid arthritis
od: Takahiro Shiratori, i dr.
Izdano: (2020-06-01)

Anti-TNFalpha therapy for rheumatoid arthritis: an update.
od: Taylor, P
Izdano: (2003)

Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
od: Farwa Altaf, i dr.
Izdano: (2021-05-01)

The Use of Fibrinolytic Therapy in Acute Ischemic Events
od: Danny Del Duca
Izdano: (2020-12-01)

The Impact of the Fibrinolytic System on the Outcomes of Thrombolytic Therapy
od: R. E. Kalinin, i dr.
Izdano: (2025-01-01)

Highly active antiretroviral therapy increases fibrinolytic and protein activity in pregnant women
od: Evarista Odaburhine Osime, i dr.
Izdano: (2018-08-01)

Variants of intensification of immunosuppressive therapy of rheumatoid arthritis
od: E A Vasiljeva, i dr.
Izdano: (2007-04-01)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
od: Collins, R, i dr.
Izdano: (1997)

Cytokine therapy in rheumatoid arthritis.
od: Maini, R, i dr.
Izdano: (1996)

Gene therapy for rheumatoid arthritis?
od: Feldmann, M
Izdano: (2001)

Pathogenesis and therapy of rheumatoid arthritis.
od: Williams, R
Izdano: (2006)

Adjunctive Therapies in Rheumatoid Arthritis
od: Tonatiuh González Heredia, i dr.
Izdano: (2024-11-01)

Biologic therapy of rheumatoid arthritis
od: Damjanov Nemanja, i dr.
Izdano: (2009-01-01)

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
od: Thao H P Nguyen, i dr.
Izdano: (2022-01-01)

The systemic fibrinolytic activity of intrapleural streptokinase.
od: Davies, C, i dr.
Izdano: (1998)

The systemic fibrinolytic activity of intrapleural streptokinase
od: Davies, C, i dr.
Izdano: (1998)

Fibrinolytic Activity of Recombinant Mutant Streptokinase
od: Mahboobeh Mobarrez, i dr.
Izdano: (2015-04-01)

Fibrinolytic and coagulative activities of Yersinia pestis
od: Timo K. Korhonen, i dr.
Izdano: (2013-07-01)

Decreased fibrinolytic activity in Behçet's syndrome.
od: J Sousa Pinto, i dr.
Izdano: (1983-08-01)

Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis
od: Dorottya Kacsándi, i dr.
Izdano: (2023-10-01)

Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: The case for the fibrinolytic potential
od: Idell, S, i dr.
Izdano: (2017)

IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
od: P. S. Dydykina, i dr.
Izdano: (2014-12-01)